Wilms' tumour antigen 1 Immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation: a Phase II non-randomised clinical trial (WIN). (2016)
Attributed to:
A novel anti Wilms-Tumour-1 (WT1) vaccination strategy in haematological malignancy using DNA fusion vaccines deliv
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: April
Parent Publication: Southampton (UK) NIHR Journals Library